Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Health Economics Unit achievements.

R Crott¹, N Neymark

¹EORTC Data Center, Avenue E. Mounier 83, bte 11, B-1200, Brussels, Belgium. rcr@eortc.be

European Journal of Cancer (Oxford, England : 1990)

|February 23, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Treatment of supraglottic squamous cell carcinoma with advanced technologies: observational prospective evaluation of oncological outcomes, functional outcomes, quality of life and cost-effectiveness (SUPRA-QoL).

BMC cancer·2023

Same author

A systematic review of the predictive value of 18F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013

Same author

Economic impact of antidepressant treatment duration in naturalistic conditions.

Acta psychiatrica Scandinavica·2012

Same author

Growth monitoring for short stature: update of a systematic review and economic model.

Health technology assessment (Winchester, England)·2011

Same author

The cost-effectiveness of screening for colorectal cancer.

Expert review of pharmacoeconomics & outcomes research·2009

Same author

Assessment of the economic value of epoetin use in anemic cancer patients.

Expert review of pharmacoeconomics & outcomes research·2009

Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026

Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026

Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026

Same journal

Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience.

European journal of cancer (Oxford, England : 1990)·2026

Same journal

Corrigendum to "Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed" [Eur J Cancer 202, May 2024, 114006].

European journal of cancer (Oxford, England : 1990)·2026

Same journal

Letter to the editor Re: Patient-reported outcomes from the LAURA study: Osimertinib in patients with unresectable stage III EGFR-mutated non-small cell lung cancer after definitive chemoradiotherapy.

European journal of cancer (Oxford, England : 1990)·2026

See all related articles

The EORTC Health Economics Unit evaluates cancer treatment costs and benefits. This research provides crucial economic data for healthcare decision-makers choosing between therapies.

Area of Science:

Health Economics
Oncology
Clinical Trials

Background:

Established in 1994, the EORTC Health Economics Unit focuses on economic evaluations of cancer treatments.
The unit aims to inform healthcare decision-makers about the cost-effectiveness of various therapeutic options.

Observation:

Economic data collection is integrated into Phase III randomized controlled clinical trials by EORTC collaborative groups.
Studies utilizing data from sources beyond EORTC trials have also been conducted and published.

Findings:

Integrated economic evaluations from clinical trials are nearing maturity for analysis.
Several publications have resulted from these integrated studies, with more in press.

Implications:

Related Experiment Videos

Provides valuable economic information to guide healthcare policy and resource allocation in oncology.
Contributes to the methodological advancement of health economic evaluations in clinical research.